FDA Person
Department of Health and Human ServicesSamir C. Gala
View detailed information about Samir C. Gala, including compliance records, violations, and related data.
Person Profile
FDA investigator, Department of Health and Human Services. Took part in 27 inspections of 26 companies, 2023–2026.
Inspections (27)
| Date | Company | Classification | Project area | Inspection |
|---|---|---|---|---|
| August 28, 2026 | R.L. Fine Chem Private Limited | Not classified | #1338440 | |
| August 21, 2026 | InstaPill Private Limited | Not classified | #1336264 | |
| June 17, 2026 | Linde Inc. | Not classified | #1326372 | |
| March 27, 2026 | Benefit Coatings Inc. | Not classified | #1313790 | |
| February 6, 2026 | Miyoshi America, Inc | Not classified | #1306728 | |
| November 19, 2025 | Topiox Research Centre Private Limited | Not classified | #1297432 | |
| November 14, 2025 | Lupin Limited | Not classified | #1296412 | |
| November 7, 2025 | Innova Pharmactive Private Limited | Not classified | #1294696 | |
| September 23, 2025 | Specialty Minerals, Inc. | Not classified | #1286568 | |
| March 27, 2025 | Enaltec Labs Private Limited | VAI | Drug Quality Assurance | #1265451 |
| March 21, 2025 | Alembic Pharmaceuticals Ltd (API Division, Karakhadi) | Not classified | #1267871 | |
| March 14, 2025 | Zydus Lifesciences Limited | NAI | Drug Quality Assurance | #1267513 |
| December 20, 2024 | SCA Pharmaceuticals, LLC | VAI | Drug Quality Assurance | #1252093 |
| November 7, 2024 | Milbar Laboratories, Inc. | VAI | Drug Quality Assurance | #1253807 |
| September 18, 2024 | Univar Solutions USA LLC | NAI | Drug Quality Assurance | #1250910 |
| June 28, 2024 | Vijayasri Organics Private Ltd | NAI | Drug Quality Assurance | #1245975 |
| June 21, 2024 | Lee Pharma Limited | Not classified | #1244426 | |
| May 15, 2024 | Aurobindo Pharma USA Inc | OAI | Drug Quality Assurance | #1238442 |
| January 11, 2024 | Northeast Laboratories, Inc. | NAI | Drug Quality Assurance | #1229261 |
| September 29, 2023 | Chiracon GmbH | VAI | Drug Quality Assurance | #1220725 |
Documents (19)
- 483 · Hikma Injectables USA Inc · June 8, 2022
- 483 · SCA Pharmaceuticals, LLC · December 20, 2023
- 483 · Aurobindo Pharma USA Inc · May 13, 2024
- 483 · Edge Pharma, LLC · March 30, 2020
- 483 · Italfarmaco S.A. · September 15, 2023
- 483 · Milbar Laboratories, Inc. · November 7, 2024
- 483 · Specialty Minerals, Inc. · September 23, 2025
- 483 · Centrix, Inc. · March 2, 2022
- EIR · Pine Lake Investments, Inc. · March 18, 2021
- 483 · Unipharm Inc. · October 5, 2022
- 483 · PETNET Solutions Inc. · July 28, 2021
- 483 · RK Pharma Inc. · August 12, 2022
- 483 · Miyoshi America, Inc · May 25, 2021
- 483 · American Distilling Inc. · April 26, 2022
- 483 · Brand-Nu Laboratories, Inc. · November 22, 2021
- 483 · Miyoshi America, Inc · February 6, 2026
- 483 · LeMaitre Vascular, Inc. · May 15, 2024
- 483 · Aurobindo Pharma USA Inc · June 15, 2024
- 483 · Miyoshi America, Inc · January 13, 2023
Frequently inspected with (10)
Related Office
Person Information
Name
Samir C. Gala
Title
Drug Investigator
Role
Regulatory Personnel
ID: 904c34ee-013d-4663-a87a-9cbdbcf2b40e
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.